Introduction
Heart failure (HF) affects over 5.1 million adults in United States, accounts for a significant proportion of hospitalizations and deaths among older Americans, and consumes over $30 billion per year in healthcare cost. 1, 2 The prevalence of HF is expected to increase by 25% from 2010 to 2030. 3 As a result, novel preventive approaches focused on modifying risk factors for HF are urgently needed to combat this growing epidemic.
Physical inactivity and low fitness have been identified as significant contributing factors for cardiovascular diseases (CVD). [4] [5] [6] [7] [8] [9] [10] Over the past three decades, the inverse, dose-response relationship between physical activity (PA) and risk coronary heart disease (CHD) has been well established. 8, 9, [11] [12] [13] Thus, physical inactivity is considered a major, modifiable risk factor for CHD, 14 and current American Heart Association (AHA) guidelines recommend at least 150 mins/week of moderate intensity aerobic PA to reduce the burden of CHD risk factors and the risk of CHD. 15, 16, 17 In contrast, the role of PA in reducing risk of HF has not been emphasized in existing guidelines and public health recommendations. 15 Although observational cohort studies have reported an inverse association between higher levels of PA and HF risk, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] a comprehensive assessment of the quantitative dose response association between PA and HF risk has not been previously reported. Understanding this relationship is important since recent studies suggest that there may be important differences in the mechanisms through which PA modifies HF risk and CHD risk, 20 and the dose of PA needed to significantly lower HF risk may differ from that currently recommended to reduce CHD risk. 25 Previous studies have used dose response metaanalysis of epidemiological studies to better understand the quantitative association between lifestyle risk factors such as coffee intake, dietary patterns and cardiovascular outcomes. [33] [34] [35] In established. 8, 9, [11] [12] [13] Thus, physical inactivity is considered a major, modifiable ri isk sk sk f f fac ac acto to tor r r fo fo for r r CHD, 14 and current American Heart Association (AHA) guidelines recommend at least 150 mins ns s/w /w /wee ee eek k k of of of mod od oder e ate intensity aerobic PA to re re redu du duce the burden of CH H HD D D risk factors and the n i i isk k k of CHD. 15 , 5, 5,16 16 16, 17 In con on ontras a t, , , the e e r r role o o of P P PA in in in re e edu uc u in n ng risk k o o of HF HF HF ha a as n n not ot o bee ee een n n em e emph pha a asiz i i ed i i in n n exist t ting g k gu g guid id idel el elin in ines es es a a and nd nd p p pub b ubli li lic c c he he heal al alth th th r r rec ec ecom om omme me mend nd ndat at atio io ions ns ns. 15 15 A A Alt lt ltho ho houg g ugh h h ob ob obse se serv r rvat at atio io iona na nal l l co co coho ho hort rt rt s s stu t tudi di dies es es h h hav a ave e e by guest on April 17, 2017 http://circ.ahajournals.org/ Downloaded from the present study we have utilized a similar approach and performed a dose-response metaanalysis of prospective cohort studies to determine the categorical and quantitative dose response association between PA and risk of HF. We hypothesized that there would be a dose-dependent, inverse association between PA and risk of HF.
Methods:
Literature search strategy
We followed the meta-analysis of observational studies in epidemiology protocol for performing and reporting the present meta-analysis. 36 We searched for all prospective cohort studies that examined the associations between PA and incident HF among adult participants (> 18 years of age at baseline). We systematically searched electronic databases (Medline, EMBASE and
Cochrane database) and performed additional manual searches through the reference list of original publications and review articles. We used the following key words, among others, to perform the search "physical activity," "walking", "exercise", "exercise training", "cardiorespiratory fitness", "fitness", "heart failure risk", "cardiac failure risk" (full search term available on request). The search was restricted to articles that focused on human participants and were published between January 1 st , 1995 and September 24 th 2014. The time restriction was applied to reflect likely changes in PA categorization for analyses by investigators after publication of the 1995 US Centers for Disease Control and Prevention/American College of Sports Medicine guideline.
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Study Selection
Prospective cohort studies that reported the association between baseline PA levels and incident Coch ch hra ra rane ne ne d d dat at ataba a ase) e e and performed additional ma ma manu nu nual searches through h h th th the reference list of o o orig g ginal publi ica a ati ti tio ons s s an an and d d re re revi vi view ew ew a a art rt tic ic icle le les. W W We e e u u used d t th he f f fol ol ollo lo lowi wi wing ng key ey ey w w wor or o ds, am am amon on ng g g ot ot o he he hers s s, , to to to pe e erf rf rfo or orm the e se se sear rch ch ch "ph h hy ys y ical al l a a act c c ivit it ity y y," " " " "w wal l lki ki ing ng", " " "ex x xer r rcise se e" ", ", "e e exe e erci c c se e e t train in inin in ng" g , "c "c "car ar ardi di dior or ores es espi pi pira ra rato to tory r ry f f fit it itne ne ness ss ss" " ", " " "fi fi fitn tn tnes es ess" s" s", "h "h "hea ea eart rt rt f f fai ai ailu l lure re re ri ri risk sk sk" " ", " " "ca ca card rd rdia ia iac c c fa fa fail il ilur r ure e e ri ri risk sk sk" " " (f (f (ful l ull l l se se sear ar arch ch ch t t ter er erm m m total PA) were included in the initial study selection process. If multiple articles were published from the same cohort, we included data from the study with the most detailed report of PA levels and/or the larger sample size. Two independent investigators (AP, MK) conducted the initial screening of all titles or abstracts and then evaluated all potentially relevant articles based on full text reviews. Studies were excluded if they failed to meet all the criteria detailed above. All discrepancies regarding study inclusions were adjudicated by the senior author (JB). The study quality was assessed using the Newcastle-Ottawa quality assessment scale that allowed a total score of up to 9 points (9 representing the highest quality) summarizing eight aspects of each study.
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Data Collection
Two authors (AP, MK) independently performed the data collection using a standardized form.
The following information was recorded for each study: author, year of publication, cohort/study name, geographic location, proportion of women, prevalence of HF risk factors such as hypertension, diabetes, smoking, coronary artery disease at baseline, types of PA, PA levels, method used to estimate PA, total number of participants, total number of HF events, method of ascertainment of outcomes, follow up duration, hazard ratio/relative risk of HF and confidence intervals, and variables that were entered into the multivariable model as potential confounders.
Information on quantitative dose of PA and/or duration and intensity of PA performed per week was also recorded, as reported in the study.
Statistical Analysis
For the present meta-analysis we used hazard ratio (HR) or relative risk (as available) and 95%
confidence intervals as a measure of the effect size associated with each category of PA for all studies. In articles that studied more than one type of PA, only leisure time PA was preferentially
Data Collection
The e fo fo foll ll llow ow owin in ing g g in n nfo fo formation was recorded for eac ch h h st st study: author, year of f f p p publication, cohort/study n n nam me m , geograph h hi ic ic loc oc ca at a io io ion, n, n, p p pro ro ropo po port rt rtio io ion n n of w wom om omen, p prev v val al alen en ence ce ce o of f f HF HF F r ris is isk k k f fact tor or ors s s su su such ch ch a a as s s hy y ype pe pert r r ension on n, diab ab abetes s s, s sm s ok k kin n ng, g, g, c c cor or oron n na ar ary y a a arte e ery d di isea a ase e e at t t ba a ase se s l l lin n ne, , , ty y ype pe es o o of P P PA, P P PA A A le eve e els, me me meth th thod od od use se sed d d to to to e e est st stim im imat at ate e e PA PA PA, to to tota ta tal l l nu n numb mb mber er er o o of f f pa pa part rt rtic ic icip ip ipan an ants ts ts, to to tota ta tal l l nu n numb mb mber er er o o of f f H H HF F F ev e even en ents ts ts, me me meth th thod od od o o of f f f f f included for analysis. The primary aim of our analysis is to quantify the risk of HF that is associated with different PA levels independent of other cardiovascular and non-cardiovascular risk factor burden. Therefore, we used the results of the original studies from multivariable adjusted models with the most complete adjustment for potential baseline confounders including presence of risk factors such as hypertension (HTN), diabetes (DM), and body mass index (BMI)
for primary analysis. One study (Bell, et al.) reported separate hazard ratios for HF risk associated with different PA levels for African Americans and whites. 19 As a result, we included data from both the African American and the white cohort separately in the pooled analysis. Eight studies allowed quantitative estimation of leisure time PA levels associated with each category and were used to perform the continuous, dose-response meta-analysis. Two studies reported the dose of total PA with no separate information about the dose of leisure time PA and was not included in the quantitative analysis. 24, 32 Three studies reported the range of leisure time PA dose for each category in MET-min/week or Met-Hour/week. The other five studies reported total duration and intensity of PA (light or moderate or vigorous) associated with each category, which was used to estimate the mean dose of PA in met-min/week.
(Supplemental Methods). We assigned the median dose of PA for each category to the corresponding hazard ratio for each study. If medians for that category were not reported, we estimated the approximate medians by using the midpoints of the lower and upper bounds. For
studies with an open-ended highest physical activity level category, we assumed that the difference from the lowest range of this category to its median was equivalent to the difference between the lowest range of closest adjacent category and its median (Supplemental Table 1 ).
Continuous dose response relationships between PA (MET-mins/week) and HF risk were assessed using a generalized least squares regression model using SAS version 9.2 (SAS Corporation, Cary, North Carolina). This method is well described in the literature for metatudies reported the dose of total PA with no separate information about the dose of of of l l lei ei e su su sure re re t t tim im ime PA and was not included in the quantitative analysis. 24, 32 Three studies reported the range of eisur ur ure e e ti ti time me me P P PA do do dose for each category in MET-mi mi min/ n n week or Met-Hour r r/w /w /week. The other five analyses of epidemiological studies having multiple risk estimates per study and accounts for appropriate variance-covariance relationships between and within studies. [33] [34] [35] This model uses the multiple data points available in all studies simultaneously to provide the best overall pooled estimate of the dose-response in a single estimation. Non-linear relationship between PA and HF risk was assessed by modeling PA dose with use of restricted cubic splines with three knots at fixed centiles (5%, 50% and 95%) of the distribution. We first estimated a restricted cubic spline model with a generalized least squares regression, considering the correlation within each set of reported hazard ratios. We then combined the study specific estimates, using the restricted maximum likelihood method in a multivariate random effects meta-analysis. We used the PA vs.
HF risk dose-response curve to determine the reduction in HF risk among individuals engaging in PA at minimum guideline recommended levels (500 MET-min/week) as well as two times (1000 MET-min/week) and four times (2000 MET-min/week) the minimum guideline recommended levels.
Results
Characteristics of Included Studies
The study selection process and results from the literature search are shown in Figure 1 . We included twelve cohort studies with 370,460 participants and 20,203 HF events over a median follow up of 13 years. Baseline characteristics of the included studies are shown in Table 1 . Ten studies included cohort study participants and two included participants of randomized controlled trials (CARE Study and Physician Health Study). Two studies included only men; two included only women and eight included both men and women. Eight studies were conducted in United States and four were conducted in Europe. European study cohorts had a lower burden of co-morbidities such as diabetes and hypertension as compared to US study cohorts. Seven HF risk dose-response curve to determine the reduction in HF risk among individu du dual al als s s en en enga ga gagi gi ging ng ng n PA at minimum guideline recommended levels (500 MET-min/week) as well as two times 100 0 00 0 0 ME ME MET-T-T-mi m m n/ n/ n/w w week) and four times (2000 MET ET ET---min/week) the minim im imum guideline e e eco o ommended d le le leve els s s.
Results studies included participants with prevalent coronary artery disease or previous myocardial infarction history at baseline. Among studies that reported baseline characteristics stratified by physical activity levels (n = 8), pooled prevalence of cardiovascular risk factors such as HTN, DM and smoking was greater in lowest PA category as compared with highest PA category. 
Study Quality, Publication Bias and Subgroup analysis
Assessment of study quality yielded an average score of 8.4 (9 representing the highest quality), and 11 studies had a score of 6.5 or above (Supplemental Table 2 ). We did not observe a significant publication bias in the present meta-analysis (P-value for Egger's line regression test:
0.75; P-value Begg's rank correlation test: 0.54 Supplemental Figure 4 ).
To confirm the robustness of our study findings, we conducted sensitivity analyses evaluating the association between the highest levels of PA and HF risk among the following subgroups: studies with quantitative assessment of PA only (n=8); studies without history of myocardial infarction or prevalent coronary artery disease among participants at baseline (n=5); studies with low (<10%, n = 8) and high incidence (>10%, n = 4) of HF on follow-up. We also conducted additional sensitivity analysis excluding studies with significantly different study populations (Lewis, et al. with post MI population) or effect sizes as compared to other studies (Bell, et al. African-American cohort). We did not observe any significant change in the magnitude or direction of the effect size for association between highest levels of PA and HF risk with these sensitivity analyses (Supplemental Table 3 ). To determine the impact of Assessment of study quality yielded an average score of 8.4 (9 representing the h h hig ig ighe he hest st stua ua uali li lity ty ty), and 11 studies had a score of 6.5 or above (Supplemental Table 2 ). We did not observe a ign nif if ific ic ican an ant t t pu pu public c cat at a ion bias in the present meta-a a ana na naly l l sis (P-value for Egg gg gger e e 's line regression test: 0 0 0.75 5 5; P-value Be Be Begg g's s s r r ran n ank k k co co corr rr rrel el elat at atio io ion te t t st: 0. 0 0 5 5 54 Su up p pple le em me ment nt ntal a a F F Fig g gur ure e e 4 4) ).
To c c con on onfirm rm rm the e e r r robus s stn tn tne es e s of of of our ur ur stu u udy dy dy fin ndi i ing g gs, we e e c con on ndu du duc c cted e e s s se ensi i iti t t v v vity a a ana na nalyse ses ev e eval al alua a uati ti ting ng ng t t the he he a a ass ss ssoc oc ocia ia iati ti tion on on b b bet et etwe e ween en en t t the he he h h hig ig ighe he hest st st le le leve e vels ls ls o o of f f PA PA PA a a and nd nd H H HF F F ri ri risk sk sk a a amo mo mong ng ng t t the he he f f fol ol ollo lo lowi i wing ng ng multivariable adjustment, we also conducted a sensitivity analysis pooling hazard ratios from Table 3 ).
Discussion
To our knowledge, the present meta-analysis is the largest and most comprehensive evaluation of the dose-response relationship between PA and HF risk in the general population. We observed two important findings in this study. First, there is a linear, dose dependent, inverse association between PA and HF risk. This relationship was observed with both categorical as well as continuous quantitative estimates of PA levels, and is consistent across age, sex and geographical region based subgroups. Second, guideline recommended minimum PA levels are associated with only modest reductions in HF risk, and higher doses of PA may be required to reduce significantly the risk of HF.
The dose response association between PA and atherosclerotic CVD has been previously reported. 16 , 40 Sattelmair, et al. 16 observed an inverse dose-response association between PA and CHD risk with significant reductions in CHD risk with levels of PA at par or even lower than the current guideline-recommended minimum dose of PA (500 MET-min/week). In the present study, we observed a similar inverse dose-response association between PA and HF risk.
To our knowledge, the present meta-analysis is the largest and most comprehensive evaluation o he do do dose se se-r -r -res es espo p p ns s se re r r lationship between PA and HF HF HF risk in the general po po popu p p lation. We observed w w wo o o important fi fi find n ndin n ng g gs i i in n n th th this is s s s st tu tudy dy dy. . Fi F F rs st, t t the he here r is s a a a lin n nea ea ear, d d dos os o e e de e epe pend nd nde ent, i i inv nv nver r rse se se a ass ss ssoc oc ocia ia iati ti tion on on be e etw tw twee e e n PA A A a a and d H H HF ri i isk k k. Th h his is r r relat at atio io i n n nsh hi h p p wa wa was ob bse erv v ved d d w w with h h bo bo both h h c c cat a eg eg egoric ic ical al al as we we well a as co co cont nt ntin in inuo o uous s usua a uant nt ntit it itat at ativ i ive e e es es esti ti tima ma mate te tes s s of of of P P PA A A le le leve e vels ls ls, a a and nd nd i i is s s co co cons ns nsis is iste te tent nt nt a a acr cr cros os oss s s ag ag age e e, s s sex e ex a a and nd nd g g geo eo eogr gr grap ap aphi hi hica ca ca a and 500 MET-min/week, respectively. At higher doses of PA, the magnitude of reduction in HF risk was similar to that reported for CHD (~ 20% risk reduction for HF and CAD at 1000 METmin/week). However, while Sattelmair et, al. observed a plateau in the risk reduction for CAD at doses higher than 1000 MET-min/week, we observed a linear dose response for HF risk with marked reduction in risk at very high doses of PA (~35% risk reduction at 2000 METmin/week). These findings suggest that while current guideline recommended minimum levels of PA might be sufficient to mitigate CHD risk, considerably higher levels of PA may be required to achieve more robust reductions in risk for incident HF.
This difference in the magnitude of risk reduction for HF vs. CHD could be related to differences in the mechanism through which PA modifies the risk of these diseases. This is supported by previous studies from our group that have shown a stronger association between fitness and HF risk as compared with MI risk among healthy individuals. 20 PA predominantly lowers risk of CHD through favorable changes in the risk factor profile such as lowering of BP, LDL and non-HDL cholesterol. 41 Findings observed in recent studies suggest that the association between low PA/fitness levels and CHD risk is attenuated after adjustment for prevalent traditional cardiovascular risk factors. 42, 43 In contrast, the relationship of low PA/fitness levels is independent of interval development of these risk factors and is more likely related to direct effects of PA/fitness on cardiac structure and function. [44] [45] [46] [47] 48 Non-cardiac marked reduction in risk at very high doses of PA (~35% risk reduction at 2000 ME ME MET-T-Tmin/week). These findings suggest that while current guideline recommended minimum levels o PA m m mig ig ight ht ht b b be e e suff ff ffic ic icient to mitigate CHD risk, con on ns s sid id iderably higher levels ls s o o of PA may be required o o o a a achieve more e e ro obu u us s st r r red ed educ uc ucti ti tio on ons s s i i in n n ri ri risk k f f for or r in n ncid den n nt HF HF HF.
This s d d diffe e fere e ence e e i in i the e e m m mag ag gni ni nit tu t de de de of r r ris sk sk re edu u uct t tio io ion n fo fo or HF HF HF v v vs. s. C CHD H HD co co oul ul uld be e e r r rela ate ed to di di diff ff ffer er eren en ence ce ces s s in in in t t the he he m m mec ec echa ha hani ni nism sm sm t t thr hr hrou o ough gh gh whi hi hich ch ch P P PA A A mo mo modi di difi fi fies es es t t the he he r r ris is isk k k of of of t t the he hese se se d d dis is isea ea ease se ses s s. T T Thi hi his s s is is is mechanisms may also contribute to the observed dose-dependent inverse association between PA and HF risk. HF is a systemic syndrome and previous studies have identified subclinical dysfunction in multiple non-cardiac organ systems including lungs, skeletal muscle, neuroendocrine system, and peripheral vasculature as significant risk factors for HF. 48 Higher levels of PA are associated with a lower antecedent burden of these non-cardiac risk factors, which may reduce future HF risk.
47, 49-51
Age related decline in left ventricular compliance and diastolic function have been implicated in development of heart failure, particularly heart failure with preserved ejection fraction. [52] [53] [54] [55] In a recent study Bhella, et al. 48 observed that high levels of lifetime exercise (i.e. 4-5 times per week) were associated with more favorable left ventricular compliance. In contrast,
there were no differences in left ventricular compliance between sedentary and casual exercisers (i.e. 1-2 times per week). 56 Thus, doses of PA in excess of current guideline recommendations may be required to achieve favorable changes in cardiac structure and function and lower HF risk.
We observed similar reduction in risk of HF with higher levels of PA among men and women. This is in agreement with prior studies that have shown no sex-based differences in the association between PA and CVD risk factors such as blood pressure, fitness and metabolic syndrome. 57 In contrast, Sattelmair et al 16 observed that the association between PA and CHD risk was stronger in women than in men. The mechanisms underlying this difference in interaction by sex between the two studies remain unclear but could also reflect differences in the physiological mechanisms through which PA modifies the risk of HF vs. CHD.
Our study findings may have important public health implications. HF is a growing public health problem, and there is an urgent need for novel preventive strategies that can be 5 times per week) were associated with more favorable left ventricular compliance ce ce. I I In n n co co cont nt ntra ra ras s st, here were no differences in left ventricular compliance between sedentary and casual exercisers i.e. 1-1-1-2 2 2 ti ti time me mes s s pe e er we w w ek). 56 implemented at a population level. 58 The present study highlights the dose of PA required for HF prevention, providing quantitative measures of the magnitude of the risk reduction associated with different levels of PA. These findings may help guide physicians and health policy-makers in making recommendations about the dose of PA for optimal HF prevention at both the individual and the population level.
There are several strengths to our study. First, the pooled sample size of our metaanalysis was large with a long duration of follow-up. Second, we were able to quantify the amount of PA and assess the risk of HF associated with specific, quantitative levels of PA. Third, we used risk estimates from fully adjusted models for the pooled analysis to reduce the potential for confounding. Fourth, we did not observe any significant statistical heterogeneity across the studies included in the present meta-analysis. Fifth, to confirm the robustness of our study findings we performed several sensitivity and subgroup analyses, and we observed no significant change in the magnitude or the direction of the effect for the association between PA levels and HF risk.
This study also has several important limitations. First, because this is a meta-analysis of observational studies, the results could be subject to unmeasured or residual confounding.
However, because of the large number of included studies with different study characteristics, we were able to conduct numerous sensitivity analyses across different subgroups of interest suggesting the robustness of our findings. Second, there could be errors in the measurement of PA since it was assessed in most studies by using questionnaires or self reported frequency of light/moderate/vigorous PA. However, measurement error tends to bias toward the null, and therefore it is unlikely that measurement error contributed to the dose-response relationship observed in the present study. Third, we could not compare the association of different types of for confounding. Fourth, we did not observe any significant statis t tical heterogene e eit it ity y y ac ac acro ro ross ss ss t t the he he tudies included in the present meta-analysis. Fifth, to confirm the robustness of our study find din in ings gs gs w w we e e pe p p rf f for or orme m m d several sensitivity and su u ubg bg bgr r roup analyses, and w w we e e observed no significant u u u ch ch chan an ange in the ma ma magn nit it tu ud ude e e or or or the he he d d dir ir irec ec ecti ti tio on on of f f th th the e ef ff fec ct f f for or or t the he he a ass s oc oc oci ia iati ti tion on on b betwe we ween en en P P PA A A le le leve ve vels ls ls a a and nd nd HF HF HF r r ris i i k.
Th Th This is is s s stu t tudy d dy a a als ls lso o o ha ha has s s se se seve e vera ra ral l l im im impo po port rt rtan an ant t t li li limi mi mita ta tati ti tion on ons s s. Fi Fi Firs rs rst t t, b b bec ec ecau a ause se se t t thi hi his s s is is is a a a m m met et eta a a-an an anal al alys s ysis is is o o of f f f PA (For example, leisure time PA vs. occupational PA) with HF risk given the amount of detail on subtypes of PA reported from prior studies 26, 27 Fourth, differential adjustment for confounders across different studies could potentially influence our study findings. However, this was not observed on pooled analyses using HR associated with models with vs. without adjustment for cardiovascular risk factors. Finally, quantitative estimates of PA were not available in all studies. However, the studies included in the quantitative dose response analysis (8 of 12) represent more than 80% of the overall pooled study population.
In conclusion, we observe an inverse dose-dependent association between physical activity and risk of HF. Furthermore, our study findings suggest that doses of physical activity in excess of current guideline recommended minimum levels (500 MET-min/week) might be Fi i igu gu gure r 2. P Poo oo ooled estimates of the relative risk of i i inc cident HF asso so soc ciated with different categories of o o p p physical activ vity y. T Th he e high gh gh physi ical l activi i ity y y gro ou u up rep ep epre re rese s s n n nts pa pa particip p pa ants s s in n n each ch ch s s study dy y wit t th high h hes es est t t do do dos s se of f f ph ph phys ys ysic ic ical al al a a activit it ity y y wh wh while th th the e e mo mo mode de der ra rate te a and nd nd l l lig ig ight ht ht phy hy ysi si sica ca cal l l ac acti ti tivity ty y g g gro ro rou ups re repr pres e esen ent t t 
Supplemental Figure 4:
Inverted funnel plot for assessment of publication bias. 
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